RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenografts

Marina Ciscar(Institut d'Investigació Biomédica de Bellvitge), Eva González‐Suárez(Institut d'Investigació Biomédica de Bellvitge)

bioRxiv (Cold Spring Harbor Laboratory)

December 14, 2021

10.1101/2021.12.13.470911

Cited by 0

Related Papers

Chromosome 12p Amplification in Triple-Negative/ <i>BRCA1-</i> Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity

|Cancer Research|2019|19